SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001393905-18-000008
Filing Date
2018-01-09
Accepted
2018-01-09 11:08:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #1 ptgdg_13da.htm SC 13D/A 26230
  Complete submission text file 0001393905-18-000008.txt   27704
Mailing Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3
Business Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3 416-929-1806
PORTAGE BIOTECH INC. (Subject) CIK: 0001095435 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-81765 | Film No.: 18518308
SIC: 1311 Crude Petroleum & Natural Gas

Mailing Address C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Business Address
Doogan Declan (Filed by) CIK: 0001704234 (see all company filings)

Type: SC 13D/A